|
|
|
|
| Advertisement |
Watch this brief video to hear how trusted case managers can drive patient adherence and better outcomes using in-home education and tele-health support.
 Learn more |
| Advertisement |
 NORD's Rare Diseases and Orphan Products Breakthrough Summit is the most meaningful multi-stakeholder event – historically featuring over 20 speakers from the FDA, participation from over 80 patient organizations and the Pharma/Biotech industry’s foremost experts in orphan product innovation, investment and commercialization.
The 2016 Summit is your opportunity to address the progress and innovations in rare disease diagnosis, treatment, engagement and access of orphan products. |
|
| Advertisement |
Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
Live Webinar: Tuesday, June 7, 2016 at 1-2 pm EDT
 Free registration |
|
| Europe |
|
|
Brexit and UK Pharma
|
Eleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the European Union
... /Read more/ |
|
|
| Advertisement |
Breaking the Circle of Distrust with a Radical PLC Pricing Model
LIVE WEBCAST: Thursday, June 30, 2016 at 10 am EDT | 3 pm BST | 4 pm CEST
 Free registration |
|
| Advertisement |
Strategic considerations for clinical development programs in emerging biopharma companies
On Demand
 Learn more |
| Calendar |
|
|
| Advertisement |
Understanding the Chronic Disease Patient Journey in Emerging Markets
On Demand
 Learn more |
|
|
|
 |
| Advertisement |
Precision asset valuation Leveraging insights from clinical and market access big data
On Demand
 Learn more |
|
| Industry update |
| //Lakewood-Amedex Inc. (Sarasota, FL) appointed Steve Miley, M.D., as Chief Medical Officer and Steven A. Kates, Ph.D., to as Chief Scientific Officer and Vice President, Regulatory Affairs.//EAS Consulting Group (Alexandria, VA) appointed Bryan J. Coleman as Senior Director Pharmaceutical & Device Consulting Services.//CEO Guy Ezekiel is stepping down as CEO of Brainsway (Jerusalem, Israel) after less than a year in the role.// |
| Advertisement |
Medical science liaisons Optimizing their impact during product launch
On Demand
 Learn more |
|
|
|
| |
|
|
